Add Your Heading Text Here
Professional and high net worth investors increasingly look for return drivers that are not dictated by equity indices, interest-rate cycles, or public market sentiment. That shift is not about chasing novelty. It is about building portfolios with exposures that behave differently when conditions change.
Litigation funding loan notes sit inside that conversation because the underlying driver is distinct. Outcomes are linked to legal processes and case fundamentals rather than price movements in listed markets. For investors who already allocate to private markets, this can be a relevant form of diversification, provided it is assessed with the same discipline applied to other alternatives.
This article explains litigation funding loan notes in plain English, with the level of detail sophisticated investors expect. It covers how the asset class works, why it is often described as uncorrelated, where risk sits, and what suitability really means.
What are litigation funding loan notes?
Litigation funding, also referred to as legal finance or third-party funding, is a financial arrangement where a funder provides capital to support legal proceedings in exchange for an agreed share of proceeds if the case succeeds. It is widely used in commercial litigation and arbitration, often to manage cost and risk or unlock value tied up in legal claims.
In an investment context, litigation funding loan notes are a structured way for investors to gain exposure to this asset class. Rather than buying public securities, investors allocate capital linked to legal claims that have been assessed for merit and economic viability, where recoveries are tied to settlement or award outcomes.
Two clarifications matter:
- Litigation funding is not the same as traditional lending.
- Litigation funding is not a short-term trade.
It is a private market strategy with a legal outcome driver, which changes how investors should assess risk, duration, and portfolio fit.
Why litigation funding is often described as uncorrelated
Litigation funding is frequently described as uncorrelated because returns are driven primarily by legal outcomes rather than financial market performance. A legal claim does not succeed because equity markets rise, and it does not fail because inflation prints higher than expected. It progresses through a legal process governed by jurisdiction, procedure, evidence, settlement dynamics, and enforceability.
That does not mean litigation funding is risk-free. It means the risk is different. It sits in legal fundamentals and structure rather than market pricing.
Practical Law has directly questioned the assumption of perfect lack of correlation and makes the point that correlation can be less, rather than none, depending on how the strategy is implemented. That is a helpful framing for professional investors. “Uncorrelated” should never be treated as a marketing label. It should be treated as a hypothesis that needs to be validated through structure and case selection.
A more disciplined way to think about it is this: litigation funding can introduce a return driver that is not primarily market-linked, which can support diversification when combined thoughtfully with other alternatives.
How litigation funding works in practice
At a high level, a litigation funding strategy follows a process similar to other specialist private market exposures: sourcing, assessment, structuring, monitoring, and resolution.
- Sourcing and screening
Legal claims are screened for viability and relevance. Not all claims are fundable. Sophisticated investors should assume that a meaningful proportion of opportunities do not progress beyond early screening.
- Due diligence on legal merits and economics
Due diligence typically reviews:
- strength of legal arguments and evidence
- jurisdiction and procedural pathway
- estimated duration and cost profile
- realistic recovery potential and enforcement considerations
This is where professional investors should pay attention. Litigation funding is not driven by narrative. It is driven by the quality of the underlying case and its enforceability.
- Structuring the funding terms
Structure defines:
- when capital is deployed and whether it is staged
- how recoveries are prioritised
- what protections exist within the legal documentation
- how risk is allocated between parties
This is why structure matters more than headlines. Two claims with similar surface features can behave very differently based on the terms, the jurisdiction, and the resolution pathway.
- Ongoing oversight
Litigation strategies typically require ongoing monitoring of case progression, settlement discussions, and procedural risk.
- Resolution and recovery
If the case is successful, recoveries flow according to the agreed structure. If it fails, outcomes can range from partial recovery to total loss, depending on the strategy design.
One important structural element that is often referenced is the non-recourse nature of litigation funding, where repayment generally occurs only if the case succeeds. Deminor explains this “no cure, no pay” characteristic clearly.
Where risk really sits
Professional investors should treat litigation funding risk as specific and multi-layered. The key is not to label the asset class as high or low risk in general terms. The key is to understand where risk sits within a given structure.
Legal merit risk
The underlying strength of the legal claim is foundational. Weak merits increase probability of loss regardless of how attractive the narrative may look.
Jurisdiction and enforceability risk
A strong claim in theory may still face challenges depending on jurisdiction, procedure, or enforcement realities.
Duration risk
Litigation does not run on trading timelines. Duration varies by:
- jurisdiction
- case complexity
- court schedules
- settlement dynamics
- appeal and enforcement pathways
This is why litigation funding is not a short-term trade. Time horizon is part of risk.
Counterparty and execution risk
The quality of legal teams, claimant alignment, and governance standards influence execution.
Structure risk
Structure is where risk is either controlled or left exposed. Structure influences:
- how capital is deployed
- whether exposure is concentrated or diversified
- how recoveries are prioritised
- what protections exist in documentation
If investors want a single sentence to remember, it is this: legal merit and structure drive outcomes.
What sophisticated investors should assess before allocating
A useful approach is to assess litigation funding loan notes with the same discipline applied to other private market strategies. Investors should be able to answer the following without ambiguity:
- What is the role in the portfolio?
Is the allocation intended to provide diversification away from public markets, exposure to a different return driver, or a specific income profile? If the role is unclear, allocation decisions will become reactive.
- What is the time horizon and liquidity reality?
Litigation timelines can extend. Investors should assume illiquidity and assess whether that fits portfolio constraints.
- How is risk allocated and controlled?
What protections exist? How is capital deployed? How are recoveries prioritised? How is exposure diversified?
- How are cases selected and assessed?
What is the due diligence framework? What is the threshold for proceeding? What is rejected and why?
- What would cause the investor to change view?
Professional investors define decision triggers. That includes changes in legal fundamentals, time horizon drift, enforcement risk, or structural weaknesses identified post-allocation.
Litigation funding within alternative portfolios
Litigation funding can sit alongside other alternative strategies such as private credit, real assets, and structured finance. Its primary contribution is the potential introduction of a different return driver.
However, portfolio benefits depend on three conditions:
- the investor understands the driver
- risk and structure are properly assessed
- the time horizon aligns with the portfolio’s constraints
Without those, the allocation becomes noise rather than diversification.
FAQ: Litigation funding loan notes explained
1. What are litigation funding loan notes?
Litigation funding loan notes are structured instruments that provide exposure to litigation funding, where returns are linked to case outcomes such as settlements or awards rather than market pricing.
2. Why is litigation funding described as uncorrelated?
Because outcomes are driven primarily by legal processes and case fundamentals rather than public market movements. Correlation can vary depending on structure and case selection.
3. Is litigation funding non-recourse?
Litigation funding is commonly described as non-recourse or “no cure, no pay”, meaning repayment occurs if the case succeeds. The exact terms depend on the structure.
4. How long do litigation funding investments take?
Duration varies widely by jurisdiction, complexity, settlement dynamics, appeals, and enforcement. Investors should treat time horizon as a core suitability factor.
5. Where does risk sit in litigation funding?
Risk typically sits in legal merit, enforceability, duration, execution, and structure. Structure influences how exposure is controlled and how recoveries are prioritised.
6. How should investors think about suitability?
Suitability depends on portfolio role, time horizon, liquidity constraints, and the investor’s ability to assess structure and risk placement.
Additional reading and context
For investors who want to go deeper on how the legal finance market is described by established industry sources, the following are useful starting points:
- Burford Capital’s introduction to legal finance (overview and use cases). Burford Capital
- Deminor’s explanation of litigation funding, including “no cure, no pay” features. deminor.com
- Chambers Global Practice Guides on litigation funding across jurisdictions (useful for understanding the regulatory landscape and how the market is discussed globally). Global Practice Guides
- Practical Law discussion on correlation framing (helpful nuance for sophisticated investors). disputeresolutionblog.practicallaw.com
These sources are not endorsements. They are reference points to understand how the asset class is described in the market.
Want To Know More & Download Our Guide?
You can also explore WIUS Resources and investor education on our website, including the Private Investor Readiness Scorecard, to pressure-test whether alternatives fit your portfolio approach.
Disclaimer:
This content is for general information only and does not constitute investment advice or a recommendation. All investments involve risk, and your capital is at risk. Opportunities discussed are intended for professional, high net worth, sophisticated and institutional investors only. Private market investments can be illiquid and complex, and you could lose all invested capital.
Written by Mark Boyes
Co-Founder, WIUS Capital
With over 15 years of experience in international financial services, Mark has managed and advised on assets exceeding $100 million across five continents. He has held directorships at two leading international financial advisory firms and built a strong reputation for delivering results in competitive markets. At WIUS Capital, Mark focuses on structuring litigation-backed and asset-secured private credit opportunities for professional investors worldwide, alongside advising private companies on capital raising and sustainable growth. Known for his transparency and strategic mindset, he is committed to helping investors and businesses secure long-term results.
Meet the Founders https://wiuscapital.com/meet-the-founders/
